EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evolution‐Guided Discovery of Antimycobacterial Triculamin‐Like Lasso Peptides

Aske Merrild iD, Tiziana Svenningsen iD, Marc G Chevrette iD, Thomas Tørring iD

Angewandte Chemie International Edition · 12.05.2025 · 64 (20)

DOI: 10.1002/anie.202425134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 05.03.2025. Verfasst von Aske Merrild und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological & Chemical Engineering, Aarhus University, Gustav Wieds vej 10D, 8000, Aarhus, Denmark. Hauptthemen laut MEDLINE: Peptides, Anti-Bacterial Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Carlsbergfondet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triculamin is a ribosomally synthesized and post‐translationally modified peptide (RiPP) lasso peptide with potent antimycobacterial activity, produced by an unusual, non‐canonical biosynthetic gene cluster (BGC). In this study, we elucidate the biosynthetic pathway of triculamin through heterologous expression and show that the biosynthesis proceeds in the presence of a precursor (triA), macrocyclase (triC), and N‐acetyltransferase (triT). Through in vitro triT acetylation and bioactivity assays, we show that acetylation functions as a resistance mechanism. Genomic searches of triculamin BGC genes across bacteria show that triculamin is more widely distributed than previously anticipated, as triculamin‐like core peptides are found in at least three phyla in contrast to previously described lasso peptides that are typically restricted to one phylum. Triculamin BGCs with both canonical and non‐canonical RiPP biosynthetic genes were identified. Two strains containing canonical triculamin‐like BGCs were chemically characterized and shown to produce the novel triculamin‐like lasso peptides palmamin and gelatinamin, the latter of which appears to have an unprecedented additional ring formation. Detailed phylogenetic investigation of the macrocyclases from triculamin‐like BGCs suggests that these molecules are products of convergent evolution. These findings broaden the evolutionary and functional landscape of lasso peptides, revealing their unexpected diversification and cross‐phylum distribution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesAnti-Bacterial AgentsMultigene FamilyMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Antibiotic discoveryConvergent evolutionHeterologous expressionLasso peptidesRiPPs

Substanzen

PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biological & Chemical Engineering, Aarhus University, Gustav Wieds vej 10D, 8000, Aarhus, Denmark.
  • Department of Microbiology & Cell Sciences, University of Florida, Gainesville, Florida, USA.
  • University of Florida Genetics Institute, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Aske Merrild, Tiziana Svenningsen, Marc G Chevrette, Thomas Tørring

Förderung

  • Carlsbergfondet

Zitieren

APA

Merrild, A., Svenningsen, T., Chevrette, M. G., & Tørring, T. (2025). Evolution‐Guided Discovery of Antimycobacterial Triculamin‐Like Lasso Peptides. Angewandte Chemie International Edition, 64(20). https://doi.org/10.1002/anie.202425134

Vancouver

Merrild A, Svenningsen T, Chevrette MG, Tørring T. Evolution‐Guided Discovery of Antimycobacterial Triculamin‐Like Lasso Peptides. Angewandte Chemie International Edition. 2025;64(20). doi:10.1002/anie.202425134

BibTeX
@article{Merrild2025,
  author = {Merrild, Aske and Svenningsen, Tiziana and Chevrette, Marc G and Tørring, Thomas},
  title = {Evolution‐Guided Discovery of Antimycobacterial Triculamin‐Like Lasso Peptides},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {20},
  doi = {10.1002/anie.202425134}
}
Kostenlos starten →